An interventional study of Written Educational Material on Fibromyalgia and Asynchronous Microlearning Intervention on Fibromyalgia in Fibromyalgia, Fibromyalgia (FM) and Fibromyalgia Syndrome, sponsored by Instituto Neurociencia Del Dolor. Not yet recruiting at 1 site in Chile. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-08.
Sponsored by Instituto Neurociencia Del Dolor · Not applicable, Interventional, and Health services research
This randomized controlled pilot trial will evaluate the feasibility and preliminary effects of an asynchronous microlearning intervention on fibromyalgia knowledge among Primary Health Care workers. Participants will be randomly assigned in a 1:1 ratio to either a control group receiving evidence-based written educational material on fibromyalgia or an experimental group receiving the same written material plus an approximately 5-minute asynchronous educational microlearning video. Participants will have two weeks to review the assigned educational content. Fibromyalgia knowledge will be assessed using the Fibromyalgia Knowledge Questionnaire (FKQ) at baseline, before randomization, and two weeks later. Trial feasibility will be assessed through recruitment, retention, intervention participation, and assessment completion indicators.
ibromyalgia is a chronic primary pain condition characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, cognitive difficulties, and functional limitations. Despite advances in its understanding, relevant knowledge gaps regarding its diagnosis, underlying mechanisms, and management persist among healthcare professionals. In Primary Health Care settings, strengthening knowledge about fibromyalgia may contribute to more evidence-informed clinical practice. Proyecto FIBROK-PILOT final FIBROK-PILOT is a randomized controlled pilot trial designed to evaluate the feasibility and preliminary effects of a brief asynchronous microlearning intervention on fibromyalgia knowledge among Primary Health Care workers at CESFAM San Vicente in Talcahuano, Chile. The trial will use a two-arm parallel design with a 1:1 allocation ratio. The target is to randomize 68 participants (34 per group), allowing for an anticipated loss of up to 10% and aiming to obtain at least 60 post-intervention assessments. Proyecto FIBROK-PILOT final Proyecto FIBROK-PILOT final Participants assigned to the control group will receive an evidence-based written educational document on fibromyalgia. The material will be approximately 2-4 pages in length, with an estimated reading time of approximately 5 minutes, and will address three main areas: conceptualization and diagnosis, pathophysiological mechanisms, and pharmacological and non-pharmacological management. Proyecto FIBROK-PILOT final Participants assigned to the experimental group will receive the same written educational material plus an approximately 5-minute asynchronous educational microlearning video covering the same core topics. The video will be available asynchronously, allowing participants to access it according to their availability. Both groups will have two weeks to review their assigned educational content. Proyecto FIBROK-PILOT final Fibromyalgia knowledge will be assessed using the Fibromyalgia Knowledge Questionnaire (FKQ) at baseline, before randomization, and two weeks after baseline. The FKQ consists of 18 items and provides a total score ranging from 0 to 26, with higher scores indicating greater fibromyalgia knowledge. The preliminary effect of the intervention will be estimated by comparing post-intervention FKQ scores between groups while adjusting for baseline FKQ scores. Proyecto FIBROK-PILOT final As a pilot trial, the primary focus will be on feasibility rather than confirmatory effectiveness. Feasibility will be assessed through recruitment, retention, participation in the assigned educational intervention, and completion of study assessments. The findings will be used to determine whether this educational strategy is feasible in a Primary Health Care setting and to provide preliminary estimates that may inform the design of a future definitive trial
1,336 studies on the registry are indexed under Fibromyalgia; 266 are open to participants now.
This study's planned enrollment of 68 is above the median of 60 across 1,035 interventional studies indexed under Fibromyalgia.
Browse Fibromyalgia studies →Instituto Neurociencia Del Dolor is the lead sponsor of 6 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Participants assigned to the control group will receive evidence-based written educational material on fibromyalgia. The material will consist of a 2-4 page digital document with an estimated reading time of approximately 5 minutes, covering fibromyalgia conceptualization and diagnosis, pathophysiological mechanisms, and pharmacological and non-pharmacological management. Participants will have two weeks to review the material.
Behavioral: Written Educational Material on Fibromyalgia
Participants assigned to the experimental group will receive the same evidence-based written educational material provided to the control group, plus an approximately 5-minute asynchronous educational microlearning video. The video will cover key aspects of fibromyalgia conceptualization and diagnosis, pathophysiological mechanisms, and pharmacological and non-pharmacological management. Participants will have two weeks to review the assigned educational content.
Behavioral: Written Educational Material on Fibromyalgia · Behavioral: Asynchronous Microlearning Intervention on Fibromyalgia
Participants will receive a 2-4 page digital educational document containing evidence-based information on fibromyalgia. The material will cover three core areas: conceptualization and diagnosis, pathophysiological mechanisms, and pharmacological and non-pharmacological management. The estimated reading time is approximately 5 minutes. The material will be available for review during a two-week period.
Participants assigned to the experimental arm will additionally receive an approximately 5-minute asynchronous educational microlearning video on fibromyalgia. The video will address three core areas: conceptualization and diagnosis (approximately 2 minutes), pathophysiological mechanisms (approximately 1.5 minutes), and pharmacological and non-pharmacological management (approximately 1.5 minutes). The video will be available asynchronously during the two-week intervention period.
Recruitment rate
Proportion of eligible invited Primary Health Care workers who provide informed consent and are randomized. Calculated as the number of participants randomized divided by the total number of eligible workers invited, multiplied by 100. Higher percentages indicate greater recruitment feasibility.
Time frame: From start of recruitment until completion of recruitment, up to 3 months
Retention rate
Proportion of randomized participants who complete the post-intervention assessment. Calculated as the number of participants completing the post-intervention assessment divided by the total number randomized, multiplied by 100. Higher percentages indicate greater retention feasibility.
Time frame: 2 weeks after baseline and randomization
Assessment Completion Rate
Proportion of scheduled FKQ assessments completed by participants. Completion will be assessed for the baseline and post-intervention evaluations. Higher percentages indicate greater assessment feasibility.
Time frame: Baseline and 2 weeks after baseline
Intervention participation rate
Participation in the assigned educational intervention. Receipt of the written educational material will be recorded in both groups. In the experimental group, access to and completion of the asynchronous microlearning video will also be recorded using available platform data or participant self-report when platform data are unavailable.
Time frame: During the 2-week intervention period
Fibromyalgia Knowledge Questionnaire (FKQ) Total Score
Fibromyalgia knowledge will be assessed using the Fibromyalgia Knowledge Questionnaire (FKQ), an 18-item questionnaire with a total score ranging from 0 to 26 points. Higher scores indicate greater knowledge about fibromyalgia. The preliminary intervention effect will be estimated by comparing post-intervention FKQ total scores between groups, adjusted for baseline FKQ scores.
Time frame: Baseline and 2 weeks after baseline
FKQ General Knowledge Domain Score
Score for the general knowledge domain of the Fibromyalgia Knowledge Questionnaire (FKQ). Scores will be calculated according to the original FKQ scoring system and described by study group and assessment time. Higher scores indicate greater knowledge within this domain. This outcome will be analyzed descriptively and exploratorily.
Time frame: Baseline and 2 weeks after baseline
FKQ Treatment and Medication Domain Score
Score for the treatment and medication domain of the Fibromyalgia Knowledge Questionnaire (FKQ), including knowledge related to treatment, medication, and possible side effects. Scores will be calculated according to the original FKQ scoring system and described by study group and assessment time. Higher scores indicate greater knowledge within this domain. This outcome will be analyzed descriptively and exploratorily.
Time frame: Baseline and 2 weeks after baseline
FKQ Activities of Daily Living and Energy Conservation Domain Score
Score for the activities of daily living domain of the Fibromyalgia Knowledge Questionnaire (FKQ), including knowledge related to energy use and conservation. Scores will be calculated according to the original FKQ scoring system and described by study group and assessment time. Higher scores indicate greater knowledge within this domain. This outcome will be analyzed descriptively and exploratorily.
Time frame: Baseline and 2 weeks after baseline
FKQ Physical Activity Domain Score
Score for the physical activity domain of the Fibromyalgia Knowledge Questionnaire (FKQ). Scores will be calculated according to the original FKQ scoring system and described by study group and assessment time. Higher scores indicate greater knowledge within this domain. This outcome will be analyzed descriptively and exploratorily.
Time frame: Baseline and 2 weeks after baseline
Plan to share: No — Individual participant data will not be shared because the informed consent and the current study protocol do not include provisions for sharing individual-level data with external researchers. Study results will be disseminated in aggregate form to protect participant confidentiality.
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Instituto Neurociencia Del Dolor